Hi Bob
Allan Kohler interviewed Vince relative to the phase 2 acne trial. Vince was quite bullish about the result of the Australian arm of the trial. The link to the interview is below. I’m interested to see more of the antimicrobial work being undertaken by Botanix. I believe that management are very interested in the antimicrobial platform as mentioned at the AGM and in the recent announcement dated 13th March.
I’m personally looking at the antimicrobial as the future of this company and am hoping to see more antimicrobial announcements released in the near future.
disallowed link/investment-news/did-botanix-get-it-wrong/146272
kind regards
BBH
Hi BobAllan Kohler interviewed Vince relative to the phase 2...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $441.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 28.0¢ | $599.4K | 2.107M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 647996 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 275 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
-0.010 ( 0.04 %) |
||||
| Open | High | Low | Volume | ||
| 29.0¢ | 29.0¢ | 28.0¢ | 1016190 | ||
| Last updated 15.54pm 30/05/2024 ? | |||||
| BOT (ASX) Chart |